J. Grydehøj

FRI0190 Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry

B. Glintborg, M. Hetland, S. Chrysidis, 2017 .

A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry

A. Loft, I. Hansen, B. Glintborg, 2017, Annals of the rheumatic diseases.

Normal salivary production using a swab method in clinical settings

Therese Ovesen, J. Grydehøj, Patrick Rønde Møller, 2022, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

Levetiracetam in spinal cord injury pain: a randomized controlled trial

I. L. Johannesen, F. Biering-Sørensen, T. Jensen, 2009, Spinal Cord.

Validity and completeness of rheumatoid arthritis diagnoses in the nationwide DANBIO clinical register and the Danish National Patient Registry

A. Loft, J. Sørensen, L. Dreyer, 2017, Clinical epidemiology.

To switch or not to switch: results of a nationwide guideline of mandatory switching from originator to biosimilar etanercept. One-year treatment outcomes in 2061 patients with inflammatory arthritis from the DANBIO registry

A. Loft, I. Hansen, F. Mehnert, 2018, Annals of the rheumatic diseases.

One-Year Clinical Outcomes in 1623 Patients with Inflammatory Arthritis Who Switched from Originator to Biosimilar Etanercept: – an Observational Study from the Danish Danbio Registry

A. Loft, I. Hansen, B. Glintborg, 2017 .

Effectiveness and drug adherence of biologic monotherapy in routine care of patients with rheumatoid arthritis: a cohort study of patients registered in the Danish biologics registry.

H. Bliddal, V. Sørensen, R. Christensen, 2015, Rheumatology.

A nationwide non-medical switch from originator infliximab to biosimilar CT-P13 in 802 patients with inflammatory arthritis: 1-year clinical outcomes from the DANBIO registry

A. Loft, I. Hansen, B. Glintborg, 2017, Annals of the rheumatic diseases.